| Ms Rochelle Claire Bullock, LCSW | |
|
1215 Sw G St, Grants Pass, OR 97526-2544 | |
| (541) 476-2373 | |
| Not Available |
| Full Name | Ms Rochelle Claire Bullock |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 6 Years |
| Location | 1215 Sw G St, Grants Pass, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396032991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | L10521 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Options For Southern Oregon | 0941202006 | 34 |
News Archive
An innocent mistake made by a graduate student in a Northwestern Medicine lab (she accidentally used male mice instead of female mice during an experiment) has led scientists to a novel discovery that offers new insight into why women are more likely than men to develop autoimmune diseases such as multiple sclerosis (MS).
The Life Sciences Discovery Fund (LSDF) today announced over $1 million in five awards to support commercial development of new health and health-care products within both the non-profit and for-profit sectors in Washington.
States made little progress in improving health care access, quality, and outcomes and lowering costs in the five years preceding implementation of the major coverage provisions of the Affordable Care Act (2007-2012), according to the Commonwealth Fund's third state health system scorecard. The majority of states declined or failed to improve on two-thirds of the 34 scorecard indicators that could be tracked over time.
For the second consecutive year, a Case Western Reserve University School of Medicine researcher has landed one of the year's much-coveted Director's New Innovator Awards from the National Institutes of Health. Principal investigator Rong Xu, PhD, assistant professor of medical informatics, will receive $2,377,000 for five years, starting immediately, to initiate computational analysis of thousands of drugs and their effects.
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
› Verified 3 days ago
| Entity Name | Options For Southern Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558366492 PECOS PAC ID: 0941202006 Enrollment ID: O20070217000062 |
News Archive
An innocent mistake made by a graduate student in a Northwestern Medicine lab (she accidentally used male mice instead of female mice during an experiment) has led scientists to a novel discovery that offers new insight into why women are more likely than men to develop autoimmune diseases such as multiple sclerosis (MS).
The Life Sciences Discovery Fund (LSDF) today announced over $1 million in five awards to support commercial development of new health and health-care products within both the non-profit and for-profit sectors in Washington.
States made little progress in improving health care access, quality, and outcomes and lowering costs in the five years preceding implementation of the major coverage provisions of the Affordable Care Act (2007-2012), according to the Commonwealth Fund's third state health system scorecard. The majority of states declined or failed to improve on two-thirds of the 34 scorecard indicators that could be tracked over time.
For the second consecutive year, a Case Western Reserve University School of Medicine researcher has landed one of the year's much-coveted Director's New Innovator Awards from the National Institutes of Health. Principal investigator Rong Xu, PhD, assistant professor of medical informatics, will receive $2,377,000 for five years, starting immediately, to initiate computational analysis of thousands of drugs and their effects.
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rochelle Claire Bullock, LCSW 1545 Harbeck Rd, Grants Pass, OR 97527-5605 Ph: (541) 476-2373 | Ms Rochelle Claire Bullock, LCSW 1215 Sw G St, Grants Pass, OR 97526-2544 Ph: (541) 476-2373 |
News Archive
An innocent mistake made by a graduate student in a Northwestern Medicine lab (she accidentally used male mice instead of female mice during an experiment) has led scientists to a novel discovery that offers new insight into why women are more likely than men to develop autoimmune diseases such as multiple sclerosis (MS).
The Life Sciences Discovery Fund (LSDF) today announced over $1 million in five awards to support commercial development of new health and health-care products within both the non-profit and for-profit sectors in Washington.
States made little progress in improving health care access, quality, and outcomes and lowering costs in the five years preceding implementation of the major coverage provisions of the Affordable Care Act (2007-2012), according to the Commonwealth Fund's third state health system scorecard. The majority of states declined or failed to improve on two-thirds of the 34 scorecard indicators that could be tracked over time.
For the second consecutive year, a Case Western Reserve University School of Medicine researcher has landed one of the year's much-coveted Director's New Innovator Awards from the National Institutes of Health. Principal investigator Rong Xu, PhD, assistant professor of medical informatics, will receive $2,377,000 for five years, starting immediately, to initiate computational analysis of thousands of drugs and their effects.
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
› Verified 3 days ago
Mr. Scott E. Willi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1181 Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-2373 Fax: 541-476-1526 | |
Stephen Raleigh I, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1181 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-2373 | |
Suellen Mitzner Willi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2576 New Hope Rd, Grants Pass, OR 97527 Phone: 541-479-1544 | |
Mr. Robert Lewis Morse, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1181 Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-2373 Fax: 541-476-1526 | |
Jason Matthew Brown, B.A. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 715 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-956-5463 | |
Elizabeth Anne Mabry, CSWI Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1701 Nw Hawthorne Ave, Grants Pass, OR 97526 Phone: 541-471-3455 | |
Pamela Mccorkle, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 217 Ne C St, Grants Pass, OR 97526 Phone: 541-630-0079 |